Safety and quality of life of CDK4/6 inhibitors therapy for hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: a multicenter cross... by Benlong Yang, Zhengkui Sun, Quchang Ouyang, Zhongsheng Tong, Shu Wang, Hongyuan Li, Zhaofeng Niu, Yiding Chen, Lin-xiaoxi Ma, Haoqi Wang, Mu Tang, Zheyu Hu, Xueqiang Gao, Xu Wang, Fei Xie, Qiao Cheng, Yong Shen, Cuizhi Geng, Haibo Wang, Jiong Wu

Subjects: “…Abemaciclib…”
Get full text

Refractory diarrhea in a patient with metastatic breast cancer with ABCB1 polymorphism: A case report by Moeko Iida, Yoshihiko Tasaki, Akiko Kato, Tomoya Yasujima, Hiroaki Yuasa, Yasuhiro Maeda, Yoshihisa Mimura, Kunihiro Odagiri, Yuka Kimura, Nanami Ito, Yasuhiro Horita, Yosuke Sugiyama, Yuji Hotta, Tatsuya Toyama, Yoko Furukawa-Hibi

Subjects: “…Abemaciclib…”
Get full text

PRACTICAL ASPECTS OF ADMINISTERING CYCLIN-DEPENDENT KINASES INHIBITORS: EFFICACY AND TOLERABILITY by E. V. Artamonova

Subjects: Get full text

Annona squamosa (custard apple) leaves extract mitigates abemaciclib-induced liver injury (AILI) in male rats by Lashin S. Ali, Gamal Mohamed, Ahmed A. El-Mansy, Khaled S. El-Bayoumi, Mohammed Y. Sobhey, Abd El-Fattah B. M. El-Beltagy, Reham A. Ghanem

Subjects: “…Abemaciclib…”
Get full text

Investigation of ribociclib, abemaciclib and palbociclib resistance in ER+ breast cancer cells reveal potential therapeutic opportunities by Mashael Algethami, Ahmed Shoqafi, Ayat Lashen, Shatha Alqahtani, Jake Spicer, Ahmad ALtayyar, Çağla Tosun, Jennie N Jeyapalan, Nigel P. Mongan, Victoria James, Emad A. Rakha, Srinivasan Madhusudan

Subjects: Get full text

Modeling the impact of CDK4 / 6 inhibitors on reducing cancer mortality by N. A. Avxentyev, E. V. Bilan, A. Yu. Goryainova, Yu. V. Makarova, R. A. Murashko, A. V. Sobolev, S. V. Sharov, D. Yu. Yukalchuk

Subjects: Get full text

Case Report: Abemaciclib‐Induced Chronic Renal Failure by Lu Lin, Jinhui Chen, Jing Li, Shuangxin Liu, Weihua Lai

Subjects: “…abemaciclib…”
Get full text

Risk factors for adverse reactions caused by abemaciclib in breast cancer therapy by Xianghua Quan, CaiHong Sun, Bing Han, ChuanZhou Zhang, HuaiQin Cang, Xiaomin Xing, Qie Guo

Subjects: “…abemaciclib…”
Get full text

Real-World Analysis of Adherence to Abemaciclib and Endocrine Therapy in Women with HR+/HER2− Breast Cancer by Maria Rosaria Valerio, Federica Martorana, Maria Vita Sanò, Daniela Sambataro, Gianmarco Motta, Lucia Motta, Giuliana Pavone, Vittorio Gebbia, Giuseppa Scandurra

Subjects: “…abemaciclib…”
Get full text

A meta-analysis and systematic review of different cyclin-dependent kinase 4/6 inhibitors in breast cancer by Jialin Zhang, Xinyu Xu, Yeyue Zhou, Jingyang Su, Jue Wang

Subjects: Get full text

Selective cyclin-dependent kinase 4/6 inhibitors as anticancer drugs: Moving beyond hormone receptor-positive breast cancer by Tamojit Chaudhuri, K Govind Babu, K C Lakshmaiah, Lokanatha Dasappa, Linu Abraham Jacob, M C Suresh Babu, A H Rudresha, K N Lokesh, L K Rajeev

Subjects: “…Abemaciclib…”
Get full text

Abemaciclib and Letrozole in Metastatic Male Breast Cancer by Leon Schönfeld, Christian Möhring, Rouven Strobel, Hanns Leonhard Kaatsch, Stephan Waldeck, Ulrike Wagner

Subjects: “…abemaciclib…”
Get full text

Abemaciclib in combination with therapies for patients with metastatic breast cancer: a phase 1b study by Sara M. Tolaney, Komal Jhaveri, Teresa Helsten, Shannon L. Puhalla, Alison Conlin, E. Claire Dees, Muralidhar Beeram, Sonya C. Chapman, Andrew Lithio, Lacey M. Litchfield, Matthew P. Goetz

Subjects: “…abemaciclib…”
Get full text

Development of CDK4/6 Inhibitors in Gastrointestinal Cancers: Biomarkers to Move Forward by Ioannis A. Voutsadakis

Subjects: Get full text

Abemaciclib in combination with endocrine therapy for the treatment of HR-positive/HER2-negative locally advanced/metastatic breast cancer in the UK: an observational study by Judy King, Walid Fakhouri, Rosalind Jarvis, Waleed Badreldin, Gavin Harper, Carlo Palmieri, Mark Nathan

Subjects: “…Abemaciclib…”
Get full text

Effectiveness of cyclin-dependent kinase 4 and 6 inhibitors for the treatment of hormonesensitive HER2-negative metastatic breast cancer in first-line therapy: A systematic literat... by N. A. Avxentyev, I. I. Andreyashkina, E. V. Artamonova, L. V. Bolotina, E. I. Kovalenko, N. N. Sisigina

Subjects: Get full text

Abemaciclib treatment patterns and outcome in HR+/HER2- locally advanced or metastatic breast cancer: a real-world study from Kuwait and Lebanon by Anwar Al Nouri, Faisal Al Terkait, Nagi El Saghir, Hady Ghanem, Joseph Kattan, Cynthia Bishouti, Jade Dreyer, Soniya Rai, Alexandru Rosca

Subjects: Get full text

Grade III rash induced by abemaciclib in a patient with HR+/HER-2 negative breast cancer by Yu Yao, Zheng-Cai Zhu, Tao Li, Liang-He Jiao

Subjects: “…Abemaciclib…”
Get full text

Therapeutic Prospects of Abemaciclib for Patients with Endometrial Cancer by Ahmad Awada, Sarfraz Ahmad

Subjects: Get full text

Patterns of treatment and outcomes of patients with metastatic HER2-low breast cancer treated with CDK4/6 inhibitors and hormone therapy by Federico Sottotetti, Barbara Tagliaferri, Gianpiero Rizzo, Raffaella Palumbo, Giulia Chessa, Chiara Raso, Lorenzo Perrone, Alberto Malovini, Valentina Tibollo, Laura Deborah Locati, Paolo Pedrazzoli, Angioletta Lasagna

Subjects: “…abemaciclib…”
Get full text